clinical

The diagnosis of axial spondyloarthritis (axSpA) can be highly challenging because its hallmark symptom -- chronic…

Boston, MA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one…

VANCOUVER, British Columbia, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Blender Bites Limited. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), is excited to…

Stopping multiple sclerosis (MS) treatment as patients age can be a fraught decision, but there are some signposts…

Despite mostly being accurate and showing clear improvement over time and…

BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial…

No shortcuts: Weng has ensured that what China lacks in experience, it makes up for in discipline and attitude. | Photo Credit: Special Arrangement The Chinese team at the Asian Champions…

Dose response demonstrated in favor of highest tested dose of 3E10 vg/eye, including 100% reduction in supplemental anti-VEGF injections (4 of 4 evaluable patients injection-free) and a…

More often, people are turning to consumer wearable devices, such as smartwatches, to monitor their health and physical activity. Using these wearable devices, a study led by Michigan…

Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the “Company”),  a clinical stage biopharmaceutical…